Colorectal cancer is the third most common cancer worldwide, resulting in 50,000 deaths annually in the U.S. alone.

Since 1990, the global incidence of early-onset cancer has risen by 80 percent. Oncologists share what's behind the rising ...

New research reveals that updated colorectal cancer screening among younger Americans has led to significant increases in local-stage tumor detection and diagnoses.

The 55-year-old, who lived in Chaucer Avenue, Willenhall, was receiving chemotherapy and radiotherapy and was discharged on July 8 but re-admitted four days later with abdominal, bowel and pelvic ...

For some patients with gastrointestinal (GI) cancers like colorectal and pancreatic cancer, chemotherapy can cause severe, ...

Despite significant advances in early detection, surgery, radiotherapy, and systemic treatment of breast cancer, late relapse ...

Known as “black tumor,” the cancer sends about 8,000 Americans to the grave each year — here’s what you can do to avoid becoming one of them.

City of Hope® Research Spotlight offers a glimpse into groundbreaking scientific and clinical discoveries advancing lifesaving cures for patients with cancer, diabetes and other chronic, ...

Kelley Mack was said to be suffering from Diffuse midline glioma (DMG), which is a rare and aggressive brain tumor, which ...

Rectal cancer chemoradiotherapy is tied to an increased risk for second nonpelvic cancers but not second pelvic cancers.

Researchers discovered that interleukin-6 (IL-6) in colorectal cancer triggers a STAT3-to-PI3K signaling switch in cancer stem cells (CSCs), enabling potent PD-L1 upregulation and immune evasion.